Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Li J et al. - The hypothesis that early prostate cancer cells with differing biological potential may respond differently to finasteride treatment is worth testing. Ongoing studies using a systems biology approach in a preoperative prostate cancer setting are testing this hypothesis toward developing more-rational clinical interventions.

Related Articles

Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism
Cancer Research, 10/21/09    Relevance Score: 67%

Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate
Cancer Cell, 10/12/09    Relevance Score: 67%

Routine evaluation of prostate size not as effective in cancer screening
EurekAlert, 11/11/09    Relevance Score: 48%

Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/16/09    Relevance Score: 48%

Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09    Relevance Score: 47%

Today in Carcinogenesis...keeping you current

Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer
Clinical Cancer Research, 12/01/09

Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
Oncogene, 11/30/09

Association of rare MSH6 variants with familial breast cancer
Breast Cancer Research and Treatment, 11/25/09